These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 26307033)
1. Psychopharmacological Agents and Suicide Risk Reduction: Ketamine and Other Approaches. Al Jurdi RK; Swann A; Mathew SJ Curr Psychiatry Rep; 2015 Oct; 17(10):81. PubMed ID: 26307033 [TBL] [Abstract][Full Text] [Related]
2. New pharmacotherapies to tackle the unmet needs in bipolar disorder: a focus on acute suicidality. Kotzalidis GD; Fiaschè F; Alcibiade A; Monti L; Di Segni F; Mazza M; Sani G Expert Opin Pharmacother; 2024 Mar; 25(4):435-446. PubMed ID: 38517222 [TBL] [Abstract][Full Text] [Related]
3. Suicide Has Many Faces, So Does Ketamine: a Narrative Review on Ketamine's Antisuicidal Actions. Lengvenyte A; Olié E; Courtet P Curr Psychiatry Rep; 2019 Dec; 21(12):132. PubMed ID: 31797066 [TBL] [Abstract][Full Text] [Related]
4. Ketamine for Treatment of Suicidal Ideation and Reduction of Risk for Suicidal Behavior. Mallick F; McCullumsmith CB Curr Psychiatry Rep; 2016 Jun; 18(6):61. PubMed ID: 27194043 [TBL] [Abstract][Full Text] [Related]
6. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action. Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038 [TBL] [Abstract][Full Text] [Related]
7. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder. DiazGranados N; Ibrahim LA; Brutsche NE; Ameli R; Henter ID; Luckenbaugh DA; Machado-Vieira R; Zarate CA J Clin Psychiatry; 2010 Dec; 71(12):1605-11. PubMed ID: 20673547 [TBL] [Abstract][Full Text] [Related]
8. [Psychopharmaceuticals for treatment of suicidal patients and for suicide prevention]. Haußmann R; Bauer M; Lewitzka U; Müller-Oerlinghausen B Nervenarzt; 2016 May; 87(5):483-7. PubMed ID: 26952239 [TBL] [Abstract][Full Text] [Related]
9. Treatments for the Prevention and Management of Suicide: A Systematic Review. D'Anci KE; Uhl S; Giradi G; Martin C Ann Intern Med; 2019 Sep; 171(5):334-342. PubMed ID: 31450239 [TBL] [Abstract][Full Text] [Related]
11. Suicide risk assessment and intervention in people with mental illness. Bolton JM; Gunnell D; Turecki G BMJ; 2015 Nov; 351():h4978. PubMed ID: 26552947 [TBL] [Abstract][Full Text] [Related]
12. Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial. Grunebaum MF; Galfalvy HC; Choo TH; Keilp JG; Moitra VK; Parris MS; Marver JE; Burke AK; Milak MS; Sublette ME; Oquendo MA; Mann JJ Am J Psychiatry; 2018 Apr; 175(4):327-335. PubMed ID: 29202655 [TBL] [Abstract][Full Text] [Related]
13. The rapid anti-suicidal ideation effect of ketamine: A systematic review. Hochschild A; Grunebaum MF; Mann JJ Prev Med; 2021 Nov; 152(Pt 1):106524. PubMed ID: 34538369 [TBL] [Abstract][Full Text] [Related]
14. Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression. Price RB; Iosifescu DV; Murrough JW; Chang LC; Al Jurdi RK; Iqbal SZ; Soleimani L; Charney DS; Foulkes AL; Mathew SJ Depress Anxiety; 2014 Apr; 31(4):335-43. PubMed ID: 24668760 [TBL] [Abstract][Full Text] [Related]
15. Robust Antidepressant Effect Following Alternating Intravenous Racemic Ketamine and Electroconvulsive Therapy in Treatment-Resistant Depression: A Case Report. Bartova L; Weidenauer A; Dold M; Naderi-Heiden A; Kasper S; Willeit M; Praschak-Rieder N J ECT; 2017 Sep; 33(3):e31-e32. PubMed ID: 28520578 [No Abstract] [Full Text] [Related]
16. Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors. De Berardis D; Fornaro M; Valchera A; Cavuto M; Perna G; Di Nicola M; Serafini G; Carano A; Pompili M; Vellante F; Orsolini L; Fiengo A; Ventriglio A; Yong-Ku K; Martinotti G; Di Giannantonio M; Tomasetti C Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30249029 [TBL] [Abstract][Full Text] [Related]
17. Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial. Murrough JW; Soleimani L; DeWilde KE; Collins KA; Lapidus KA; Iacoviello BM; Lener M; Kautz M; Kim J; Stern JB; Price RB; Perez AM; Brallier JW; Rodriguez GJ; Goodman WK; Iosifescu DV; Charney DS Psychol Med; 2015 Dec; 45(16):3571-80. PubMed ID: 26266877 [TBL] [Abstract][Full Text] [Related]
18. The Suicidal Patient: Evaluation and Management. Norris DR; Clark MS Am Fam Physician; 2021 Apr; 103(7):417-421. PubMed ID: 33788523 [TBL] [Abstract][Full Text] [Related]
19. Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression. Newport DJ; Carpenter LL; McDonald WM; Potash JB; Tohen M; Nemeroff CB; Am J Psychiatry; 2015 Oct; 172(10):950-66. PubMed ID: 26423481 [TBL] [Abstract][Full Text] [Related]
20. What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities. Strasburger SE; Bhimani PM; Kaabe JH; Krysiak JT; Nanchanatt DL; Nguyen TN; Pough KA; Prince TA; Ramsey NS; Savsani KH; Scandlen L; Cavaretta MJ; Raffa RB J Clin Pharm Ther; 2017 Apr; 42(2):147-154. PubMed ID: 28111761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]